Marksans Pharma’s arm gets UK MHRA approval for Cetirizine Dihydrochloride

20 Nov 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem in the UK, has received Marketing Authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its product Cetirizine Dihydrochloride 1 mg/ml Oral Solution.

Earlier, the company’s wholly owned subsidiary -- Marksans Pharma Inc had received the final approval for Abbreviated New Drug Application (ANDA) from United States Food and Drug Administration (USFDA) for Loperamide Hydrochloride Tablets USP, 2 mg (OTC).

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.


Marksans Pharma Share Price

168.00 10.85 (6.90%)
01-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1728.45
Dr. Reddys Lab 1209.20
Cipla 1195.90
Zydus Lifesciences 863.45
Lupin 2273.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×